Sign In
Buy CLPT
$13.30
+0.93 (+7.52%)
At Close: Jun 03, 2026
ClearPoint Neuro to Present at the UBS Global Healthcare Virtual Conference
04:05pm, Wednesday, 19'th May 2021
SOLANA BEACH, Calif., May 19, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the br
Clearpoint Neuro's (CLPT) CEO Joe Burnett on Q1 2021 Results - Earnings Call Transcript
11:03pm, Tuesday, 11'th May 2021
Clearpoint Neuro's (CLPT) CEO Joe Burnett on Q1 2021 Results - Earnings Call Transcript
SOLANA BEACH, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the br
Earnings Preview: ClearPoint Neuro, Inc. (CLPT) Q1 Earnings Expected to Decline
03:47pm, Tuesday, 04'th May 2021
ClearPoint Neuro, Inc. (CLPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ClearPoint Neuro to Announce First Quarter 2021 Results May 11, 2021
04:38pm, Thursday, 29'th Apr 2021
SOLANA BEACH, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the
ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
05:00pm, Friday, 23'rd Apr 2021
SOLANA BEACH, Calif., April 23, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the
ClearPoint Neuro, Inc. Announces Retirement of Director John N. Spencer, Jr.
04:05pm, Tuesday, 13'th Apr 2021
SOLANA BEACH, Calif., April 13, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the
IRVINE, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro: A Biotech Portfolio Play
08:00am, Monday, 05'th Apr 2021
ClearPoint Neuro: A Biotech Portfolio Play
ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee as General Counsel
04:05pm, Wednesday, 24'th Mar 2021
IRVINE, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain,
ClearPoint Neuro, Inc. (CLPT) Surges 12.8%: Is This an Indication of Further Gains?
06:49am, Tuesday, 23'rd Mar 2021
ClearPoint Neuro, Inc. (CLPT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further streng
Clearpoint Neuro, Inc. (CLPT) CEO Joseph Burnett on Q4 2020 Results - Earnings Call Transcript
10:51pm, Thursday, 04'th Mar 2021
Clearpoint Neuro, Inc. (CLPT) CEO Joseph Burnett on Q4 2020 Results - Earnings Call Transcript
ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates
07:43pm, Thursday, 04'th Mar 2021
ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 30.77% and 0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stoc
Recap: ClearPoint Neuro Q4 Earnings
04:33pm, Thursday, 04'th Mar 2021
Shares of ClearPoint Neuro (NASDAQ:CLPT) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 18.18% over the past year to ($0.09), which
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results
04:05pm, Thursday, 04'th Mar 2021
Company Reports Record Revenues
